Utidelone Plus Bevacizumab for Advanced Breast Cancer With Brain Metastases
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate the efficacy and safety of utidelone in combination with
bevacizumab in the treatment of advanced breast cancer with brain metastases, and thus
provides a new systemic treatment strategy for those patients.